Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Short-term Investments (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Short-term Investments for 2 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Short-term Investments fell 98.89% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 98.89% decrease, with the full-year FY2024 number at $107.5 million, changed N/A from a year prior.
  • Short-term Investments was $1.5 million for Q3 2025 at Pyxis Oncology, down from $78.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $132.8 million in Q3 2024 to a low of $1.5 million in Q2 2024.